Advertisement
Advertisement

DTIL

DTIL logo

Precision BioSciences, Inc. Common Stock

7.69
USD
Sponsored
+0.21
+2.81%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

7.50

-0.19
-2.48%

Precision BioSciences, Inc. Common Stock Profile

About

Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Info & Links

CEO

Michael Amoroso

Headquarters

302 EAST PETTIGREW STREET,SUITE A-100
DURHAM, NC 27701, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.precisionbiosciences.com

Auditor

Deloitte & Touche LLP

Share holders

30

Employees

68

Precision BioSciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

193.52M

Enterprise Value

105.10M

Enterprise Value/EBITDA(ttm)

-2.10

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.98

Price to Book(mrq)

1.64

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-171.99%

Profit Margin(ttm)

-92249.63%

Return on Equity(ttm)

-122.60%

Return on Invested Capital(ttm)

-109.41%

Return on Assets(ttm)

-48.98%

Income Statement

Revenue(ttm)

34.26M

Revenue Per Share(ttm)

1.39

Gross Profit(ttm)

34.26M

EBITDA(ttm)3

-50.08M

Net Income Available to Common(ttm)

-45.72M

Diluted EPS(ttm)

-5.13

Share Statistics

Beta (5Y Monthly)

1.09

52-Week Change

49.32%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.73M

Dividend Yield

0.00%

Float4

24.64M

% Held by Insiders

4.50%

% Held by Institutions

37.99%

Balance Sheet

Total Cash(mrq)

115.58M

Total Cash Per Share(mrq)

4.67

Total Debt(mrq)

22.40M

Total Debt/Equity(mrq)

24.29%

Current Ratio(mrq)

13.32%

Quick Ratio(mrq)

13.32%

Book Value Per Share(mrq)

3.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.13

Free Cash Flow(ytd)

-65.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement